← Back
$MNPR All transactions

Monopar Therapeutics

M

$ Value

$0

Shares

4,327

Price

$0

Filed

Oct 2

Insider

Name

Cittadine Andrew

Title

Chief Operating Officer

CIK

0001863624

Roles

Officer

Transaction Details

Transaction Date

2025-09-30

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

38,674

Footnotes

Represents shares acquired on vesting and settlement of restricted stock units. | Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units. | On February 2, 2022, the reporting person was granted 13,000 restricted stock units, vesting 6/48ths (1,625 shares) on June 30, 2022, and 3/48ths (813 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. | On February 1, 2023, the reporting person was granted 15,647 restricted stock units, vesting 6/48ths (1,956 shares) on June 30, 2023, and 3/48ths (978 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. | On March 4, 2025, the reporting person was granted 40,581 restricted stock units, vesting 6/48ths (5,073 shares) on June 30, 2025, and 3/48ths (2,536 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2028. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

Filing Info

Accession No.

0001437749-25-030285

Form Type

4

Issuer CIK

0001645469

Cittadine Andrew's History

Date Ticker Type Value
2026-03-31 MNPR M
2026-03-31 MNPR F $86K
2026-03-31 MNPR M $0
2025-12-31 MNPR M
2025-12-31 MNPR F $123K
2025-12-31 MNPR M $0
2025-12-02 MNPR A $0
2025-12-02 MNPR A $0
2025-09-30 MNPR M
2025-09-30 MNPR F $155K

Other Insiders at MNPR (90d)

Insider Bought Sold Last
Robinson Chandler
Chief Executive Officer
2026-03-31
Rodriguez Susan
CCSO
2026-03-02
Cittadine Andrew
Chief Operating Officer
2026-03-31